Flavia Nelson1, Mohammad A Akhtar1, Edward Zúñiga2, Carlos A Perez3, Khader M Hasan4, Jeffrey Wilken5, Jerry S Wolinsky1, Ponnada A Narayana4, Joel L Steinberg2. 1. Department of Neurology, The University of Texas Health Science Center at Houston, Houston, TX, USA. 2. Collaborative Advanced Research Imaging (CARI), Center for Clinical and Translational Research and Department of Psychiatry, Virginia Commonwealth University, Richmond, VA, USA. 3. Departments of Pediatric and Neurology, The University of Texas Health Science Center at Houston, Houston, TX, USA. 4. Department of Diagnostic & Interventional Imaging, The University of Texas Health Science Center at Houston, Houston, Texas, USA. 5. Department of Neurology, Georgetown University Medical Center, Washington, DC, USA.
Abstract
BACKGROUND: Cognitive impairment (CI) cannot be diagnosed by magnetic resonance imaging (MRI). Functional magnetic resonance imaging (fMRI) paradigms, such as the immediate/delayed memory task (I/DMT), detect varying degrees of working memory (WM). Preliminary findings using I/DMT showed differences in blood oxygenation level dependent (BOLD) activation between impaired (MSCI, n = 12) and non-impaired (MSNI, n = 9) multiple sclerosis (MS) patients. OBJECTIVES: The aim of the study was to confirm CI detection based on I/DMT BOLD activation in a larger cohort of MS patients. The role of T2 lesion volume (LV) and Expanded Disability Status Scale (EDSS) in magnitude of BOLD signal was also sought. METHODS: A total of 50 patients (EDSS mean ( m) = 3.2, disease duration (DD) m = 12 years, and age m = 40 years) underwent the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and I/DMT. Working memory activation (WMa) represents BOLD signal during DMT minus signal during IMT. CI was based on MACFIMS. RESULTS: A total of 10 MSNI, 30 MSCI, and 4 borderline patients were included in the analyses. Analysis of variance (ANOVA) showed MSNI had significantly greater WMa than MSCI, in the left prefrontal cortex and left supplementary motor area ( p = 0.032). Regression analysis showed significant inverse correlations between WMa and T2 LV/EDSS in similar areas ( p = 0.005, 0.004, respectively). CONCLUSION: I/DMT-based BOLD activation detects CI in MS. Larger studies are needed to confirm these findings.
BACKGROUND:Cognitive impairment (CI) cannot be diagnosed by magnetic resonance imaging (MRI). Functional magnetic resonance imaging (fMRI) paradigms, such as the immediate/delayed memory task (I/DMT), detect varying degrees of working memory (WM). Preliminary findings using I/DMT showed differences in blood oxygenation level dependent (BOLD) activation between impaired (MSCI, n = 12) and non-impaired (MSNI, n = 9) multiple sclerosis (MS) patients. OBJECTIVES: The aim of the study was to confirm CI detection based on I/DMT BOLD activation in a larger cohort of MSpatients. The role of T2 lesion volume (LV) and Expanded Disability Status Scale (EDSS) in magnitude of BOLD signal was also sought. METHODS: A total of 50 patients (EDSS mean ( m) = 3.2, disease duration (DD) m = 12 years, and age m = 40 years) underwent the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and I/DMT. Working memory activation (WMa) represents BOLD signal during DMT minus signal during IMT. CI was based on MACFIMS. RESULTS: A total of 10 MSNI, 30 MSCI, and 4 borderline patients were included in the analyses. Analysis of variance (ANOVA) showed MSNI had significantly greater WMa than MSCI, in the left prefrontal cortex and left supplementary motor area ( p = 0.032). Regression analysis showed significant inverse correlations between WMa and T2 LV/EDSS in similar areas ( p = 0.005, 0.004, respectively). CONCLUSION: I/DMT-based BOLD activation detects CI in MS. Larger studies are needed to confirm these findings.
Entities:
Keywords:
BOLD; Cognitive impairment; MACFIMS; fMRI; multiple sclerosis; working memory
Authors: Jiongjiong Wang; Lin Li; Anne C Roc; David C Alsop; Kathy Tang; Norman S Butler; Mitchell D Schnall; John A Detre Journal: Magn Reson Imaging Date: 2004-01 Impact factor: 2.546
Authors: Nancy Chiaravalloti; Frank Hillary; Joseph Ricker; Christopher Christodoulou; Andrew Kalnin; Wen-Ching Liu; Jason Steffener; John DeLuca Journal: J Clin Exp Neuropsychol Date: 2005-01 Impact factor: 2.475
Authors: M A Rocca; G Riccitelli; M Rodegher; A Ceccarelli; A Falini; M Falautano; A Meani; G Comi; Massimo Filippi Journal: AJNR Am J Neuroradiol Date: 2010-03-18 Impact factor: 3.825
Authors: Maria A Rocca; Paola Valsasina; Hanneke E Hulst; Khaled Abdel-Aziz; Christian Enzinger; Antonio Gallo; Debora Pareto; Gianna Riccitelli; Nils Muhlert; Olga Ciccarelli; Frederik Barkhof; Franz Fazekas; Gioacchino Tedeschi; Maria J Arévalo; Massimo Filippi Journal: Hum Brain Mapp Date: 2014-07-18 Impact factor: 5.038
Authors: Ralph H B Benedict; Darcy Cox; Laetitia L Thompson; Fred Foley; Bianca Weinstock-Guttman; Frederick Munschauer Journal: Mult Scler Date: 2004-12 Impact factor: 6.312
Authors: M Loitfelder; F Fazekas; K Petrovic; S Fuchs; S Ropele; M Wallner-Blazek; M Jehna; E Aspeck; M Khalil; R Schmidt; C Neuper; C Enzinger Journal: Neurology Date: 2011-02-08 Impact factor: 9.910
Authors: Alexandra Kutzelnigg; Claudia F Lucchinetti; Christine Stadelmann; Wolfgang Brück; Helmut Rauschka; Markus Bergmann; Manfred Schmidbauer; Joseph E Parisi; Hans Lassmann Journal: Brain Date: 2005-10-17 Impact factor: 13.501
Authors: Zafer Keser; Arash Kamali; Kyan Younes; Paul E Schulz; Flavia M Nelson; Khader M Hasan Journal: J Neuroimaging Date: 2018-06-12 Impact factor: 2.486